George Elston, Chief Financial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), bought 10,000 shares at $0.48 ($5K) on 2020-09-04, disclosed to the SEC on 2020-09-09.
Open-market purchase of $5k EYPT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| EYPT | BUY | 2019-11-18 | $14K | — | Filing → |
| JNP | BUY | 2016-08-31 | $6K | — | Filing → |